drug
as of 2026-07-01measurements
at a glance
OTHER
Pre-approval / investigational in the US
Developed by University Hospital, Strasbourg, France
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
OTHER
Indications
Investigational (via trials)
Trials
1
Sustained Attention Abilities in Schizophrenia
NCT02388607—Unknown
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
indication
indication
KOL
Bonnefond Anne, PHD
personKOL score —
Giersch Anne, MD
personKOL score —